Literature DB >> 21248162

Regulation of blood pressure and salt homeostasis by endothelin.

Donald E Kohan1, Noreen F Rossi, Edward W Inscho, David M Pollock.   

Abstract

Endothelin (ET) peptides and their receptors are intimately involved in the physiological control of systemic blood pressure and body Na homeostasis, exerting these effects through alterations in a host of circulating and local factors. Hormonal systems affected by ET include natriuretic peptides, aldosterone, catecholamines, and angiotensin. ET also directly regulates cardiac output, central and peripheral nervous system activity, renal Na and water excretion, systemic vascular resistance, and venous capacitance. ET regulation of these systems is often complex, sometimes involving opposing actions depending on which receptor isoform is activated, which cells are affected, and what other prevailing factors exist. A detailed understanding of this system is important; disordered regulation of the ET system is strongly associated with hypertension and dysregulated extracellular fluid volume homeostasis. In addition, ET receptor antagonists are being increasingly used for the treatment of a variety of diseases; while demonstrating benefit, these agents also have adverse effects on fluid retention that may substantially limit their clinical utility. This review provides a detailed analysis of how the ET system is involved in the control of blood pressure and Na homeostasis, focusing primarily on physiological regulation with some discussion of the role of the ET system in hypertension.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21248162      PMCID: PMC3236687          DOI: 10.1152/physrev.00060.2009

Source DB:  PubMed          Journal:  Physiol Rev        ISSN: 0031-9333            Impact factor:   37.312


  878 in total

1.  Renal effects and mesangial cell contraction induced by endothelin are mediated by PAF.

Authors:  A López-Farré; D Gómez-Garre; F Bernabeu; I Montañés; I Millás; J M López-Novoa
Journal:  Kidney Int       Date:  1991-04       Impact factor: 10.612

2.  Differential effects of endothelin-1 and big endothelin on canine kidneys.

Authors:  S Akabane; H Yoshimi; K Yoshida; Y Kawano; T Ashida; O Kinoshita; Y Matsushima; M Kawamura; M Imanishi; M Kuramochi
Journal:  J Cardiovasc Pharmacol       Date:  1991       Impact factor: 3.105

3.  Effects of endothelin on regional blood flows in squirrel monkeys.

Authors:  M Clozel; J P Clozel
Journal:  J Pharmacol Exp Ther       Date:  1989-09       Impact factor: 4.030

4.  Endothelin-1 is involved in mechanical stress-induced cardiomyocyte hypertrophy.

Authors:  T Yamazaki; I Komuro; S Kudoh; Y Zou; I Shiojima; Y Hiroi; T Mizuno; K Maemura; H Kurihara; R Aikawa; H Takano; Y Yazaki
Journal:  J Biol Chem       Date:  1996-02-09       Impact factor: 5.157

5.  Activation of endogenous thromboxane A2 biosynthesis mediates presynaptic inhibition by endothelin-3 of dog stellate ganglionic transmission.

Authors:  K Kushiku; H Ohjimi; H Yamada; T Kuwahara; T Furukawa
Journal:  J Pharmacol Exp Ther       Date:  1995-01       Impact factor: 4.030

6.  Characterization of a coronary vasoconstrictor produced by cultured endothelial cells.

Authors:  K A Hickey; G Rubanyi; R J Paul; R F Highsmith
Journal:  Am J Physiol       Date:  1985-05

7.  The human preproendothelin-1 gene. Complete nucleotide sequence and regulation of expression.

Authors:  A Inoue; M Yanagisawa; Y Takuwa; Y Mitsui; M Kobayashi; T Masaki
Journal:  J Biol Chem       Date:  1989-09-05       Impact factor: 5.157

8.  Mechanisms transducing the aldosterone secretagogue signal of endothelins in the human adrenal cortex.

Authors:  Paola G Andreis; Giuliano Neri; Cinzia Tortorella; Francesco Aragona; Gian Paolo Rossi; Gastone G Nussdorfer
Journal:  Peptides       Date:  2002-03       Impact factor: 3.750

Review 9.  Kidney CYP450 enzymes: biological actions beyond drug metabolism.

Authors:  X Zhao; J D Imig
Journal:  Curr Drug Metab       Date:  2003-02       Impact factor: 3.731

10.  Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes.

Authors:  H Ito; Y Hirata; S Adachi; M Tanaka; M Tsujino; A Koike; A Nogami; F Murumo; M Hiroe
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

View more
  144 in total

Review 1.  Early progress in epigenetic regulation of endothelin pathway genes.

Authors:  A K Welch; M E Jacobs; C S Wingo; B D Cain
Journal:  Br J Pharmacol       Date:  2013-01       Impact factor: 8.739

2.  Two-photon imaging of endothelin-1-mediated intracellular Ca(2+) handling in smooth muscle cells of rat renal resistance arteries.

Authors:  Oleg Palygin; Bradley Miller; Daria V Ilatovskaya; Andrey Sorokin; Alexander Staruschenko
Journal:  Life Sci       Date:  2015-12-10       Impact factor: 5.037

3.  Target-Mediated Drug Disposition Pharmacokinetic-Pharmacodynamic Model of Bosentan and Endothelin-1.

Authors:  Anke-Katrin Volz; Andreas Krause; Walter Emil Haefeli; Jasper Dingemanse; Thorsten Lehr
Journal:  Clin Pharmacokinet       Date:  2017-12       Impact factor: 6.447

Review 4.  Proximal nephron.

Authors:  Jia L Zhuo; Xiao C Li
Journal:  Compr Physiol       Date:  2013-07       Impact factor: 9.090

5.  Role for reactive oxygen species in flow-stimulated inner medullary collecting duct endothelin-1 production.

Authors:  Will Wheatley; Donald E Kohan
Journal:  Am J Physiol Renal Physiol       Date:  2017-05-17

Review 6.  Biochemical markers of aging for longitudinal studies in humans.

Authors:  Peter M Engelfriet; Eugène H J M Jansen; H Susan J Picavet; Martijn E T Dollé
Journal:  Epidemiol Rev       Date:  2013-02-04       Impact factor: 6.222

Review 7.  Endothelin antagonists for diabetic and non-diabetic chronic kidney disease.

Authors:  Donald E Kohan; David M Pollock
Journal:  Br J Clin Pharmacol       Date:  2013-10       Impact factor: 4.335

Review 8.  Thick Ascending Limb Sodium Transport in the Pathogenesis of Hypertension.

Authors:  Agustin Gonzalez-Vicente; Fara Saez; Casandra M Monzon; Jessica Asirwatham; Jeffrey L Garvin
Journal:  Physiol Rev       Date:  2019-01-01       Impact factor: 37.312

9.  Proximal tubule-dominant transfer of AT(1a) receptors induces blood pressure responses to intracellular angiotensin II in AT(1a) receptor-deficient mice.

Authors:  Xiao C Li; Jia L Zhuo
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-02-20       Impact factor: 3.619

10.  Endothelin-A receptor antagonism modifies cardiovascular risk factors in CKD.

Authors:  Neeraj Dhaun; Vanessa Melville; Scott Blackwell; Dinesh K Talwar; Neil R Johnston; Jane Goddard; David J Webb
Journal:  J Am Soc Nephrol       Date:  2012-12-14       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.